These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 11877580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
    Zhu X, Chen J, Han F, Cheng M, Xu L, Zhang L, Ding X, Le Y.
    Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
    [Abstract] [Full Text] [Related]

  • 5. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
    Gleiter CH.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.
    Danovitch GM, Jamgotchian NJ, Eggena PH, Paul W, Barrett JD, Wilkinson A, Lee DB.
    Transplantation; 1995 Jul 27; 60(2):132-7. PubMed ID: 7624954
    [Abstract] [Full Text] [Related]

  • 8. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients.
    Usalan C, Erdem Y, Cağlar M, Altun B, Arici M, Bakkaloğlu M, Yasavul U, Turgan C, Cağlar S.
    Nephrol Dial Transplant; 1998 Nov 27; 13(11):2884-9. PubMed ID: 9829495
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
    Lezaic V, Biljanovic-Paunovic L, Pavlovic-Kentera V, Djukanovic L.
    Eur J Med Res; 2001 Jan 29; 6(1):27-32. PubMed ID: 11313188
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril.
    Noroozianavval M, Argani H, Aghaeishahsavari M, Veisi P, Ghorbanihaghjo A, Rashtchizadeh N, Jabbarpourbonyadi M, Hamzeiy H.
    Transplant Proc; 2007 May 29; 39(4):1018-22. PubMed ID: 17524880
    [Abstract] [Full Text] [Related]

  • 14. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines.
    Morrone LF, Di Paolo S, Logoluso F, Schena A, Stallone G, Giorgino F, Schena FP.
    Transplantation; 1997 Sep 27; 64(6):913-8. PubMed ID: 9326420
    [Abstract] [Full Text] [Related]

  • 15. Correction of posttransplant erythrocytosis with enalapril.
    Rell K, Koziak K, Jarzyo I, Lao M, Gaciong Z.
    Transplantation; 1994 Apr 15; 57(7):1059-63. PubMed ID: 8165703
    [Abstract] [Full Text] [Related]

  • 16. Effects of losartan on the treatment of posttransplant erythrocytosis.
    Navarro JF, García J, Macía M, Mora C, Chahin J, Gallego E, Méndez ML, del Castillo N.
    Clin Nephrol; 1998 Jun 15; 49(6):370-2. PubMed ID: 9696433
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
    Yagisawa T, Toma H, Yaguchi H, Tomaru M, Iijima Y, Suzuki H, Nakada T.
    Int Urol Nephrol; 1997 Jun 15; 29(3):363-7. PubMed ID: 9285312
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
    Torregrosa JV, Campistol JM, Montesinos M, Rogada AG, Oppenheimer F, Andreu J.
    Transplantation; 1994 Aug 15; 58(3):311-4. PubMed ID: 8053053
    [Abstract] [Full Text] [Related]

  • 19. [Effect of angiotensin-converting enzyme inhibitors on serum levels of erythropoietin in patients on peritoneal dialysis].
    Huang YH.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan 15; 22(1):74-5. PubMed ID: 12390854
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.
    Glicklich D, Burris L, Urban A, Tellis V, Greenstein S, Schechner R, Devarajan P, Croizat H.
    J Am Soc Nephrol; 2001 Sep 15; 12(9):1958-1964. PubMed ID: 11518790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.